Trials / Conditions / CD30-Positive Neoplastic Cells Present
CD30-Positive Neoplastic Cells Present
3 registered clinical trials studyying CD30-Positive Neoplastic Cells Present — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas NCT03373305 | City of Hope Medical Center | Phase 1 |
| Withdrawn | Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma NCT02729961 | University of Washington | Phase 1 / Phase 2 |
| Recruiting | Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery NCT03007030 | M.D. Anderson Cancer Center | Phase 2 |